Dmytro Kharkov

How to buy Anthropic shares before the IPO

How to buy Anthropic shares before the IPO
How to buy Anthropic shares.

​Anthropic pre-IPO shares have created significant demand, supported by AI hype and FOMO around one of the most valuable private companies. Access remains controlled: only board-approved transfers are recognized, and many secondary platforms are explicitly voided. But legitimate opportunities still exist for accredited investors. So how can you buy Anthropic shares now?

Board-approved direct secondary purchases

Anthropic’s equity is among the most tightly controlled in private markets. Currently, the company is preparing to list on Nasdaq under the ticker ANT at a range of $70–$78 per share (a fully diluted valuation may reach $1.4 trillion). Direct ownership before the IPO is severely restricted, and the public offering opens broader but competitive access. Below are the main options available to different categories of investors.

The only way to obtain recognized ownership in Anthropic’s equity structure is through a secondary transaction approved by its board. Existing shareholders (early employees or institutional holders) may sell, but only after formal consent. 

Anthropic has stated clearly: “Any sale or transfer of Anthropic stock, or any interest in Anthropic stock, that has not been approved by our Board of Directors is void and will not be recognized on our books and records.” 

The company has also prohibited transfers into special-purpose vehicles (SPVs). These opportunities are rare and available only to accredited investors with $1 million net worth excluding primary residence. 

Specialized pre-IPO and venture funds

For accredited and some retail investors, publicly accessible or interval funds that already hold Anthropic positions are the most practical option. Destiny Tech100 (DXYZ) has disclosed Anthropic exposure as high as approximately 14 percent of its assets. The ARK Venture Fund (ARKVX) and certain BlackRock and Tema vehicles have also reported high stakes, acquired through earlier approved channels or institutional SPVs.

These funds provide diversified or single-name exposure and offer lower minimums than direct secondaries. They also provide higher liquidity than pure private shares. However, investors face management fees, discounts or premiums to net asset value, and imperfect evaluation of Anthropic’s underlying performance. Javier Avalos, CEO of Caplight, states that much of the visible secondary supply has flowed through structures the company opposes.

Public-company proxies

Investors unable to meet accredited-investor standards can gain partial and liquid exposure by purchasing shares of Anthropic’s largest strategic partners. For instance, Alphabet (Google) and Amazon have made multi-billion-dollar primary investments. They also remain significant shareholders, so some investors may prefer purchasing their stock at the moment.

Buying GOOGL or AMZN shares may allow you to benefit from Anthropic’s success without any transfer-restriction risks or accreditation requirements. This offers immediate liquidity and transparency; however, it only partially reflects Anthropic’s performance. So this option may not be appropriate for some people.

Retail IPO allocation through designated brokers

The most significant near-term opportunity for ordinary investors is the IPO itself. Anthropic has indicated that up to 20 percent of the offering (this is twice as more than usual) may be allocated to individual investors. Participating U.S. brokers include Charles Schwab, Fidelity, Robinhood (including TradePMR), SoFi, and E*TRADE. Eligible customers should submit indications of interest for shares at the $70-78 IPO price range. Pricing is expected on November 18, with trading to begin on November 19.

Allocation is not guaranteed, as it is determined by account size, relationship strength, and market demand. Some brokers impose minimum asset thresholds (for example, Schwab has that around $50,000). Investors who receive shares at the offer price avoid the secondary premiums that increase private valuations above $1.5 trillion.

Open-market purchase after listing

Once ANT begins trading, any investor with a brokerage account can buy shares on the Nasdaq. This eliminates accreditation issues, board-approval requirements, and other risks. The trade-off is that the purchase price will reflect real-time public-market assessment rather than the IPO offer price. Early trading may be volatile, considering different strategies that may be utilized by big players.

Overall, legitimate pre-IPO ownership of Anthropic is mostly limited to board-approved secondaries and fund vehicles that hold approved positions. Public proxies and the upcoming IPO allocation may provide access if the first two options are not available to you. As Glen Anderson and other secondary-market participants have stressed, scarcity has determined pricing, as the public has extremely high expectations.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.